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INTRODUCTION
In South Korea, health check-ups for screening purposes have 
recently become quite popular. Due to a high incidence of gas-
tric cancer, esophagogastroduodenoscopy (EGD) is offered 
biannually in individuals older than 40 years via Korea’s Na-
tional Health Insurance check-up program. 
The prevalence of gastroesophageal reflux disease in Asia 
has increased. Prior to 2000, the prevalence of reflux esopha-
gitis diagnosed on EGD was less than 10%,1 and since then, 
has gradually increased up to 13.8%.2,3 In a national study in 
Korea from 2005 to 2008, the prevalence of reflux esophagitis 
was reported as 7.91% based on endoscopic findings at health 
check-ups (n=25536).4
Use of sedated EGD has increased to control patient anxiety 
and pain during EGD. Commonly, patients are allowed to opt 
for sedation if it is not contraindicated, since sedation im-
proves patient tolerance during the procedure. Many studies 
have been published about sedation regimens during EGD, as 
well as associated risks and benefits, with appropriate safety 
measures and monitoring practices.5,6 While EGD can be per-
formed correctly under sedation, patients may not be able to 
perform deep inspiration when examining the esophagogas-
tric junction (EGJ). Thus, sedation likely affects the diagnosis 
of gastroesophageal reflux-related findings. The EGJ is func-
tionally and anatomically complex and is not easily evaluated. 
Although the methods, degrees, and duration of sedated EGD 
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have been studied extensively, there have been no reports on 
the influence of sedation on diagnosis of disease during EGD. 
Therefore, we elected to study the implications of sedation on 
the diagnosis of upper gastrointestinal disease, particularly 
gastroesophageal reflux-related findings, during EGD.
MATERIALS AND METHODS
Patients
We performed a retrospective review of data from 28914 pa-
tients older than 20 years who underwent EGD at the Sever-
ance Hospital, Yonsei University College of Medicine, in Seoul, 
Korea from January 2011 to December 2011. A total of 28914 
patients received an EGD during the study period. We excluded 
therapeutic EGD, such as endoscopic mucosal resection, endo-
scopic submucosal dissection, percutaneous endoscopic gas-
trostomy, and hemostasis for gastrointestinal bleeding; emer-
gency EGD; and scheduled EGD after upper gastrointestinal 
malignancy treatment. Consequently, the study population 
comprised 18546 patients who received a diagnostic EGD and 
fulfilled the inclusion criteria. Of these, 10471 patients (56.4%) 
underwent non-sedated EGD and 8075 patients (43.5%) un-
derwent sedated EGD (Fig. 1). Data related to the patient’s 
characteristics and endoscopic findings were extracted.
Esophagogastroduodenoscopy
EGD was performed by experienced endoscopists who had 
each performed more than 3000 upper endoscopies and well-
trained endoscopists who performed at least more than 130 
cases, which are minimum quality requirements for compe-
tence according to a specialist medical society.7
EGD was accomplished in the left lateral decubitus posi-
tion, and patients received topical pharyngeal anesthesia with 
lidocaine spray. All patients were assessed with a history and 
physical examination prior to administering sedation to iden-
tify factors that may increase the risk of an adverse outcome. 
The sedated EGD was performed by low-dose propofol seda-
tion. Before initiation of EGD, a 20 gauge (1.0 mm) i.v. cannula 
was placed in the patient’s forearm for propofol injection. An 
additional 20 mg of propofol was injected if the target level 
was not obtained.6 Low-dose propofol was administered for 
endoscopic sedation by nurses supervised by the endosco-
pists. Both the endoscopists and nurses had basic cardiac life 
support certification.8 The target level of sedation was con-
scious sedation that maintained both ventilator and cardio-
vascular function, and allowed patients to make a purposeful 
response to verbal or tactile stimulation. Patient monitoring 
was performed in accordance with the recommendations of 
the American Society for Gastrointestinal Endoscopy.6
We used a gastrointestinal videoscope (GIF-Q260, GIF-
H260; Olympus Optical Co. Ltd., Tokyo, Japan) with an outer 
diameter of 9.2, 9.8 mm by an oral approach. Endoscopic ex-
amination of the EGJ was performed using a high-definition 
white-light endoscope without specialized equipment, such 
as chromoendoscopy or narrow band imaging, and was in-
spected as described below. We asked the patients to hold 
their breathing after deep inspiration. Then, we observed the 
EGJ when it was most widely opened during peristalsis (Fig. 2). 
The remainder of the endoscopic examination was performed 
according to the department’s standard operating procedure. 
The EGJ was defined to include the squamocolumnar junc-
tion, the proximal margin of gastric folds, the distal end of the 
palisade zone, and the location of pinchcock. Endoscopic find-
Fig. 1. Study flow diagram. EGD, esophagogastroduodenoscopy.
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ings of reflux esophagitis in the lower esophagus were classi-
fied according to the Los Angeles (LA) classification as grades A 
to D, and were based on the longest length of a mucosal break 
and the confluence of erosion. Six endoscopic criteria were 
used to define minimal change esophagitis: erythema, blurring 
of the Z-line, white turbid discoloration, decreased vascularity, 
friability, and edema or accentuation of the mucosal fold.9-11
This study protocol was approved by the Institutional Review 
Board of Yonsei University Hospital (4-2012-0124) and the study 
was conducted in accordance with the Helsinki Declaration.
Fig. 2. Typical findings at the esophagogastric junction in the non-sedated EGD group (A) and the sedated EGD group (B). EGD, esophagogastroduo-
denoscopy.
A B
Table 1. Clinical Characteristics of the 18546 Patients
Non-sedated EGD (n=10471) Sedated EGD (n=8075) Total EGD (n=18546) p value
Sex (%) <0.001
Male 5820 (55.6) 3549 (44.0) 9369 (50.5)
Female 4651 (44.4) 4526 (56.0) 9177 (49.5)
Age, yrs <0.001
Mean±SD 58.7±13.3 53.7±14.1 56.6±13.9
BMI, kg/m2 0.003
Mean±SD 23.1±3.3 23.2±3.4 23.1±3.4
Smoking 0.156
Yes 2180 (20.8) 1163 (14.4) 3343 (18.0)
No 4121 (39.4) 2342 (29.0) 6463 (34.8)
Missing 4170 (39.8) 4570 (56.6) 8740 (47.1)
Alcohol 0.981
Yes 2411 (23.0) 1342 (16.6) 3753 (20.2)
No 3890 (37.2) 2163 (26.8) 6053 (32.6)
Missing 4170 (39.8) 4570 (56.6) 8740 (47.1)
Hypertension <0.001
Yes 2498 (23.9) 1280 (15.9) 3778 (20.4)
No 4021 (38.4) 2476 (30.7) 6497 (35.0)
Missing 3952 (37.7) 4319 (53.5) 8271 (44.6)
Diabetes mellitus <0.001
Yes 1209 (11.5) 561 (6.9) 1770 (9.5)
No 5309 (50.7) 3196 (39.6) 8505 (45.9)
Missing 3953 (37.8) 4318 (53.5) 8271 (44.6)
BMI, body mass index; EGD, esophagogastroduodenoscopy.
Values are expressed as n (%). Chi-square and t-test.
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Statistical analysis
Continuous variables are expressed as the mean±standard 
deviation. The chi-square test was used to compare categorical 
variables, and a t-test was used to compare continuous vari-
ables. Logistic regression adjusted for age, sex, and body mass 
index (BMI) was used to assess the effect of sedation on the 
diagnosis of gastroesophageal reflux-related findings during 
EGD. A p-value of less than 0.05 was considered statistically 
significant. Statistical analysis was conducted using SAS 9.2 
(SAS Institute Inc., Cary, NC, USA).
RESULTS
Among the 18546 patients, 9369 (50.5%) were men and 9177 
(49.4%) were women. The mean age was 56 years (range: 20–
96 years, SD: 13.9) and the mean BMI was 23.1 (SD: 3.4). Table 1 
shows the characteristics of the study population. The data re-
vealed significant differences in clinical characteristics, such 
as sex, age, BMI, hypertension, and diabetes mellitus. Howev-
er, as data on smoking, alcohol, hypertension, and diabetes 
mellitus were missing in about half of the patients, we do not 
include these variables when comparing and analyzing seda-
tion effects during EGD. We adjusted for age, sex, and BMI 
when evaluating the collected data.
Table 2 demonstrates the reasons for diagnostic EGD, which 
we classified into evaluation for symptoms and previous find-
ings and a regular health check-up. The common purpose of 
diagnostic EGD was to evaluate gastrointestinal symptoms 
and previous EGD findings. There were no significant differ-
ences between the sedated and non-sedated groups regard-
ing the purposes of diagnostic EGD. 
Table 3 shows differences in the endoscopic findings of the 
EGJ observed between the sedated EGD group and non-se-
dated EGD group. Sedated EGD was significantly associated 
with less frequent detection of minimal change esophagitis 
[odds ratio (OR), 0.651; 95% confidence interval (CI), 0.586 to 
0.722] and hiatal hernia (OR, 0.699; 95% CI, 0.564 to 0.866) at 
the EGJ. Likewise, other findings at the EGJ, such as reflux 
esophagitis of LA classification A (OR, 0.949; 95% CI, 0.807 to 
1.116), B (OR, 0.782; 95% CI, 0.589 to 1.038), C (OR, 0.872; 95% 
CI, 0.447 to 1.700), and D (OR, 0.639; 95% CI, 0.226 to 1.805), 
and Barrett’s esophagus (OR, 0.794; 95% CI, 0.586 to 1.076), 
were also less frequently detected, although the differences 
therein between the two groups was not significant. 
Findings in the stomach, such as early gastric cancer (OR, 
1.145; 95% CI, 0.995 to 1.317), advanced gastric cancer (OR, 
0.896; 95% CI, 0.768 to 1.044), and gastric ulcer (OR, 0.963; 
Table 2. Purposes of EGD among the Study Cohort
Evaluation for symptoms and 
previous findings
Regular health check-up Total EGD p value
Non-sedated EGD 8134 (77.7) 2337 (22.3) 10471 (100) 0.051
Sedated EGD 6369 (78.9) 1706 (21.1) 8075 (100)
EGD, esophagogastroduodenoscopy.
Values are expressed as n (%). Chi-square test.
Table 3. Endoscopic Findings at the Esophagogastric Junction during Sedated and Non-Sedated EGD
Endoscopic findings Non-sedated EGD (n=10471) Sedated EGD (n=8075) OR 95% CI p value
Minimal change esophagitis 1333 (12.7) 811 (10.0) 0.651 0.586–0.722 <0.001
Reflux esophagitis with 
  LA classification A to D
609 (5.8) 447 (5.5) 0.892 0.777–1.024 0.105
LA classification A 469 (4.48) 326 (4.04) 0.949 0.807–1.116 0.530
LA classification B 173 (1.65) 98 (1.21) 0.782 0.589–1.038 0.088
LA classification C 27 (0.26) 17 (0.21) 0.872 0.447–1.700 0.687
LA classification D 14 (0.13) 5 (0.06) 0.639 0.226–1.805 0.398
Barrett’s esophagus 163 (1.6) 97 (1.2) 0.794 0.586–1.076 0.136
Hiatal hernia 348 (3.3) 157 (1.9) 0.699 0.564–0.866 0.001
EGD, esophagogastroduodenoscopy; OR, odds ratio; CI, confidence interval; LA, Los Angeles.
Values are expressed as n (%).
Table 4. Endoscopic Findings at the Stomach during Sedated and Non-Sedated EGD
Endoscopic findings Non-sedated EGD (n=10471) Sedated EGD (n=8075) OR 95% CI p value
Early gastric cancer 507 (4.8) 393 (4.9) 1.145 0.995–1.317 0.058
Advanced gastric cancer 512 (4.9) 285 (3.5) 0.896 0.768–1.044 0.160
Gastric ulcer 921 (8.8) 592 (7.3) 0.963 0.857–1.083 0.532
EGD, esophagogastroduodenoscopy; OR, odds ratio; CI, confidence interval.
Values are expressed as n (%).
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95% CI, 0.857 to 1.083), did not differ between the two groups 
(Table 4).
DISCUSSION
Conscious sedation is often performed in diagnostic and un-
complicated therapeutic EGD. The purpose of this study was 
to investigate the influence of sedation on the diagnosis of 
gastroesophageal reflux-related findings during EGD. After 
adjusting for sex, age, and BMI, diagnoses of minimal change 
esophagitis and hiatal hernia were more frequent for non-se-
dated EGD than sedated EGD (12.7% vs. 10.0% and 3.3% vs. 
1.9%, respectively). Reflux esophagitis of LA classification A to 
D was not significantly different between the sedated and 
non-sedated EGD groups in this study. 
There are two possible explanations for the greater detec-
tion of a minimal change esophagitis in non-sedated EGD. 
One reflects the sedation itself during EGD, while the other 
involves the effect of propofol on esophageal motility. Seda-
tion impacts EGJ observation in the following two ways: first, 
sedation can provide endoscopists enough time to observe 
the EGJ as long as they want, compared to non-sedated EGD. 
Second, sedation hampers performing the procedure at the 
EGJ adequately due to a lack of cooperation between the en-
doscopist and the patient with regard to breathing, which was 
observed in this study.
Deep inspiration generates negative pressure in the thorac-
ic cavity. In this interim, intraabdominal pressure increases 
and the diaphragm flattens.12 Thus, deep inspiration facilitates 
the extension of the esophagus so that the EGJ can be ob-
served easily. This may have caused the difference in the diag-
nosis of the gastroesophageal reflux-related finding between 
the two groups in this study. 
When propofol is used at a lower dose (0.3 mg/kg), there is 
no alteration in pressure of the lower esophageal sphincter. 
However, there is an increase in pressure in young patients 
(less than 30) after a high dose (0.9 mg/kg) of propofol. In our 
study, almost all patients were older than forty; therefore, pro-
pofol itself would not be expected to affect the motility of the 
esophagus.13
Minimal change esophagitis was defined as a whitish or 
reddish, edematous change and erosion that was not a muco-
sal break. The interobserver agreement for this lesion is low in 
comparison to that of reflux esophagitis LA classification A to 
D,14 so the diagnosis of this lesion must made more precisely 
and carefully. Although minimal changes are one of the endo-
scopic findings of non-erosive reflux disease, the clinical sig-
nificance of these minimal changes is controversial. In our 
previous report, most endoscopic findings indicating minimal 
changes were not related with symptoms of gastroesophageal 
reflux disease. Together with previous studies about minimal 
change esophagitis, diagnosis of minimal change esophagitis 
should be reconsidered because of low interobserver agree-
ment, as well as a lack of clinical meaning and variability in the 
methods of examination.
In Asia, several studies have been performed on the preva-
lence of endoscopy-based reflux esophagitis. The prevalence 
of endoscopic esophagitis is generally less than 10%, although 
it has been increasing in recent years.15-18 In our study, the 
prevalence of endoscopic reflux esophagitis was found to be 
5.7%, which is similar to the 7.9% prevalence rate reported in 
200517 and the 3.4% prevalence rate in 2001 for Koreans,19 al-
though lower than the prevalence observed in the West.20 Bar-
rett’s esophagus has a very low prevalence in Asia of less than 
0.03% of the general population21,22 and 2% of upper gastroin-
testinal symptoms.3 The prevalence of Barrett’s esophagus 
was 1.4% in this study. The reason for this relatively high prev-
alence was that only 21.8% of EGD was conducted as a routine 
health check-up, while the majority was conducted for the 
evaluation of upper gastrointestinal symptoms, diagnosis of 
disease, and after receiving a referral to our hospital. Although 
there was a difference (OR, 0.794; 95% CI, 0.586 to 1.076) be-
tween the sedated and non-sedated EGD groups, it was not 
statistically significant (p=0.136). 
One of the risk factors of Barrett’s esophagus is hiatal her-
nia. Hiatal hernia is defined as the persistent or recurrent her-
niation of parts of the stomach through the esophageal hiatus 
into the chest cavity.23 For accurate observation of a hiatal her-
nia, the endoscopist requires proper air inflation in the stom-
ach and the patient’s cooperation in breath control. Therefore, 
sedation affects the diagnosis of gastroesophageal reflux-re-
lated findings, such as minimal change esophagitis and hiatal 
hernia, as we found in this study. 
Finally, there are several limitations in our study. Firstly, this 
study was performed retrospectively. Although all endoscopic 
data were recorded prospectively and properly selected, the 
chance of bias cannot be negated. Secondly, confounding fac-
tors to have a potential effect on examination of EGJ including 
proton pump inhibitor (PPI) medication, obesity, smoking sta-
tus, and chronic airway diseases, such as chronic obstructive 
pulmonary disease and asthma, to cause airflow limitation 
were not thoroughly evaluated. This problem can be solved by 
future prospective studies. Thirdly, this study was performed at 
a tertiary referral hospital with a high prevalence of gastric 
cancer compared to the general population. Therefore, it is dif-
ficult to generalize our findings regarding the potential effect 
of sedation on diagnoses. 
In this study, we have shown that sedation during the EGD 
can affect the sensitivity of diagnosis of minimal change 
esophagitis and hiatal hernia. Sedation might interfere with 
detailed examination of the EGJ, compared to non-sedative 
EGD. However, clinically significant findings such as reflux 
esophagitis of LA classification A to D and Barrett’s esophagus 
were not influenced by sedation. Therefore, we suggest that 
patient’s sedation status should be considered while evaluat-
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ing minimal change esophagitis or hiatal hernia.
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